Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price raised by research analysts at Barclays from $38.00 to $41.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Barclays‘s price objective would indicate a potential upside of 11.93% from the company’s current price.
A number of other equities analysts have also issued reports on the company. BNP Paribas Exane upped their target price on Keurig Dr Pepper from $28.00 to $29.00 and gave the company a “neutral” rating in a research report on Monday, August 10th. Royal Bank Of Canada reissued an “outperform” rating and set a $42.00 price target on shares of Keurig Dr Pepper in a research report on Tuesday, August 4th. Bank of America lifted their price target on shares of Keurig Dr Pepper from $35.00 to $38.00 in a research note on Friday, July 10th. Piper Sandler restated an “overweight” rating on shares of Keurig Dr Pepper in a research note on Wednesday, October 14th. Finally, TD Cowen upped their price target on shares of Keurig Dr Pepper from $33.00 to $35.00 and gave the company a “hold” rating in a report on Wednesday. Ten investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $37.29.
Read Our Latest Research Report on Keurig Dr Pepper
Keurig Dr Pepper Stock Down 0.7%
Shares of Keurig Dr Pepper stock traded down $0.26 during trading hours on Thursday, hitting $36.63. 15,802,005 shares of the company’s stock traded hands, compared to its average volume of 15,076,574. The stock has a 50 day simple moving average of $32.87 and a 200-day simple moving average of $30.20. The company has a quick ratio of 0.28, a current ratio of 0.48 and a debt-to-equity ratio of 0.74. The company has a market cap of $49.85 billion, a PE ratio of 33.61, a PEG ratio of 1.75 and a beta of 0.35. Keurig Dr Pepper has a twelve month low of $24.88 and a twelve month high of $37.88.
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last announced its earnings results on Tuesday, November 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. The business had revenue of $7.34 billion for the quarter, compared to analyst estimates of $7.33 billion. Keurig Dr Pepper had a return on equity of 10.80% and a net margin of 7.10%. The company’s revenue for the quarter was up 70.6% compared to the same quarter last year. During the same period in the previous year, the company earned $0.54 earnings per share. Equities research analysts anticipate that Keurig Dr Pepper will post 2.31 earnings per share for the current fiscal year.
Insider Buying and Selling at Keurig Dr Pepper
In other news, Director Aaron Alt bought 7,862 shares of Keurig Dr Pepper stock in a transaction on Tuesday, August 25th. The shares were bought at an average price of $31.83 per share, with a total value of $250,247.46. Following the acquisition, the director directly owned 7,862 shares in the company, valued at approximately $250,247.46. This represents a ? increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Mary Beth Denooyer sold 12,000 shares of Keurig Dr Pepper stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $32.55, for a total value of $390,600.00. Following the completion of the transaction, the insider owned 84,171 shares of the company’s stock, valued at approximately $2,739,766.05. The trade was a 12.48% decrease in their position. The SEC filing for this sale provides additional information. 0.34% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Keurig Dr Pepper
Several large investors have recently added to or reduced their stakes in KDP. Vontobel Holding Ltd. increased its stake in Keurig Dr Pepper by 1.5% during the third quarter. Vontobel Holding Ltd. now owns 21,777 shares of the company’s stock valued at $661,000 after purchasing an additional 328 shares during the last quarter. Parallel Advisors LLC boosted its holdings in shares of Keurig Dr Pepper by 2.6% in the 3rd quarter. Parallel Advisors LLC now owns 13,823 shares of the company’s stock valued at $419,000 after buying an additional 353 shares during the period. WJ Financial Advisors LLC boosted its holdings in shares of Keurig Dr Pepper by 1.6% in the 1st quarter. WJ Financial Advisors LLC now owns 27,383 shares of the company’s stock valued at $721,000 after buying an additional 433 shares during the period. CX Institutional boosted its holdings in shares of Keurig Dr Pepper by 2.8% in the 3rd quarter. CX Institutional now owns 17,017 shares of the company’s stock valued at $516,000 after buying an additional 469 shares during the period. Finally, Vise Technologies Inc. grew its position in shares of Keurig Dr Pepper by 4.0% during the 3rd quarter. Vise Technologies Inc. now owns 14,081 shares of the company’s stock valued at $427,000 after buying an additional 542 shares during the last quarter. 93.99% of the stock is currently owned by institutional investors.
Key Headlines Impacting Keurig Dr Pepper
Here are the key news stories impacting Keurig Dr Pepper this week:
- Positive Sentiment: Ghost Energy has become KDP’s fourth brand with more than $1 billion in annual sales, reinforcing the scale of its energy-drink business and adding to its growth story. Ghost Energy becomes Keurig Dr Pepper’s fourth $1 billion brand
- Positive Sentiment: Analyst actions provide additional support: Barclays raised its target to $41 and kept an overweight rating, while UBS raised its target to $42 and maintained a buy rating. Higher targets suggest analysts see further potential in the shares. Barclays price target UBS price target
- Neutral Sentiment: KDP’s planned 2027 split could help investors value its beverage and coffee businesses separately. However, recent results point to a mixed outlook: beverage and energy growth contrasts with weaker coffee demand, leaving open whether the separation will create value. Keurig Dr Pepper’s Beverage Growth Raises a Tough Question About Its Coffee Split Analysts weigh split plans
- Neutral Sentiment: A comparison of beverage companies’ dividend prospects raises questions about payout resilience and financial cushions, but the supplied headline does not specify a KDP-specific conclusion. Dividend comparison of Coca-Cola, PepsiCo and Keurig Dr Pepper
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.
The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.
Further Reading
- Five stocks we like better than Keurig Dr Pepper
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.
